欧洲社区老年人衰弱与药物相关问题风险的双向关联
研究基于欧洲五国城市健康中心项目的1785名社区老年人,在基线和一年随访时重复评估衰弱与药物相关问题(MRP)风险,采用线性回归和交叉滞后面板模型分析双向关联。结果显示,基线衰弱对随访时MRP风险的关联在调整协变量后仍显著(β=0.10,95%CI:0.08,0.13),反向路径呈相似趋势,但基线衰弱至随访MRP风险的效应强于反向路径(Wald检验比较滞后效应:p<0.05)。作者认为可能形成循环,需进一步研究验证并探索潜在通路。
要点
- 基线衰弱对随访时MRP风险的调整后关联显著(β=0.10,95%CI:0.08,0.13)。
- 基线MRP风险对随访衰弱风险的关联呈相似趋势。
- 基线衰弱至随访MRP风险的效应强于反向路径(Wald检验p<0.05)。
核心结论
- 作者认为,衰弱水平较高的老年人更可能有较高的MRP风险,进而促使衰弱水平升高,可能形成循环。
- 作者指出需进一步研究验证该发现并探索潜在通路。
研究设计与样本
- 研究为纵向设计,参与者为城市健康中心欧洲项目中1785名社区老年人,来自五个欧洲国家。
- 在基线和一年随访时重复收集衰弱、MRP风险及协变量数据,采用线性回归分析单向关联,并采用交叉滞后面板模型评估双向关联。
主要发现
- 调整协变量后,基线衰弱与随访时MRP风险的关联仍具统计学显著性(β=0.10,95%CI:0.08,0.13)。
- 基线MRP风险与随访时衰弱的关联呈相似趋势。
- 双向关联与报告的单向关联相当,基线衰弱至随访MRP风险的效应强于反向路径(Wald检验比较滞后效应:p<0.05)。
局限性
- 作者指出需进一步研究验证该发现并探索潜在通路。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Studies revealed unidirectional associations between frailty and medication-related problems (MRPs) among older adults. Less is known about the association between frailty and the risk of MRPs. We aimed to assess the bi-directional association between frailty and the risk of MRPs in community-dwelling older adults in five European countries. METHODS: Participants were 1785 older adults in the population-based Urban Health Centres Europe project. Repeated assessments were collected at baseline and one-year follow-up, including frailty, the risk of MRPs, and covariates. Linear regression analyses were conducted to examine the unidirectional associations. A cross-lagged panel modeling was used to assess bi-directional associations. RESULTS: The unidirectional association between frailty at baseline and the risk of MRPs at follow-up remained statistically significant after adjusting for covariates (β = 0.10, 95%CI:0.08, 0.13). The association between the risk of MRPs at baseline and frailty at follow-up shows similar trends. The bi-directional association was comparable with reported unidirectional associations, with a stronger effect from frailty at baseline to the risk of MRPs at follow-up than reversed path (Wald test for comparing lagged effects: p < 0.05). CONCLUSION: This longitudinal study suggests that a cycle may exist where older adults with higher frailty levels are more likely to have a higher risk of MRPs, which in turn contributes to developing a higher level of frailty. Further research is needed to validate our findings and explore underlying pathways.
引用
- Ye L, Nieboer D, Yang-Huang J, et al. The association between frailty and the risk of medication-related problems among community-dwelling older adults in Europe. J Am Geriatr Soc. 2023. PMID: 36965170. doi:10.1111/jgs.18343
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。